jump to content jump to footer
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.

Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

This central question shaped this year’s “RECIST and Beyond” workshop at the Radiological Center for Integrated Oncology (radCIO) at University Hospital Cologne. Over two intensive days in late September 2025, participants received exactly the practical, hands-on insights needed for their daily clinical routine.

Radiologists, oncologists, and specialists from related fields worked in an interactive hands-on format, performing their assessments directly in mint Lesion. This allowed them to immediately apply what they learned – structured, standardized, and fully traceable.

Day 1: Response Monitoring in Modern Oncology

The program focused on RECIST 1.1, iRECIST, mRECIST, LI-RADS Treatment Response, and the Lugano Classification. Participants learned how to reliably evaluate tumor response and progression, and how standardized reporting workflows enhance consistency and clarity in clinical decision-making.

Day 2: Liver and Biliary Tract Diagnostics with a Focus on LI-RADS

Saturday was dedicated to the classification, interpretation, and treatment response assessment of HCC as well as other hepatic and biliary tumors – highlighting the correct application of LI-RADS.

Learning in a Personalized Setting

With a deliberately limited number of participants, the workshop created an ideal environment for exchange, discussion, and individual feedback.

Prof. Dr. Thorsten Persigehl, scientific dorector of the event, summarized it perfectly:

“Through the independent hands-on training at the laptops, every participant will take something valuable back into their clinical routine reporting.”

We are delighted that we were able to support this workshop with mint Lesion, enabling participants to experience firsthand how structured reporting and decision support can increase confidence in everyday oncologic imaging.

More workshops are already in planning.
Follow us on LinkedIn to stay informed.

mintLesion Standardized Reading Procedures Clinical Routine HCC Structured Reporting

Related Resources

Radiologist reviewing whole-body MRI images with AI-supported tumor burden quantification for bone metastases and multiple myeloma using mint Lesion.
Mint Medical has integrated an AI algorithm developed by The Institute of Cancer Research and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma.
The ICR and The Royal Marsden work with Mint Medical to integrate AI-powered software into cancer treatment
The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech…
Onur Özek from Mint Medical discusses the challenges, requirements, and future of lung cancer screening in Germany in an interview with RadMag.
In the latest RadMag Special Edition, Onur Özek discusses structured reporting, AI integration, second-reader workflows, interoperability, and the importance of end-to-end workflow management for lung cancer.
RadMag Special Edition: Onur Özek on the Challenges of Lung Cancer Screening in Germany
With the nationwide rollout of Germany’s lung cancer screening, radiology providers are facing new challenges. Structured reporting, mandatory second…
Mint Medical and Coreline teams coming together to announce partnership
Mint Medical and Coreline Soft integrate AVIEW into mint Lesion to support AI-enabled workflows for structured reporting, Lung-RADS assessment, and longitudinal nodule management in lung cancer screening.
Coreline Soft and Mint Medical Announce Partnership to Advance AI-Enabled Lung Cancer Screening
Coreline Soft and Mint Medical today announced a partnership to advance AI-enabled lung cancer screening, following more than six months of technical…